IFN beta:Fc (Merck Serono)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameIFN beta:Fc (Merck Serono)
Drug Alias NameIFN beta:Fc fusion (Serono)IFN beta:Fc fusion (Syntonix)interferon beta:Fc fusion (Merck Serono)interferon beta:Fc fusion (Syntonix)IFN beta:Fc fusion (Merck Serono) +[7] 
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragmentBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBioverativ Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck Serono SaBioverativ Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsMultiple Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A